Randomized prospective trial of continuous vs intermittent heparin therapy

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Heparin therapy is crucial for managing thromboembolic disorders.
• Different administration methods, continuous intravenous and intermittent bolus, exist for heparin.
• Assessing the safety profile of these administration methods is clinically important.

Purpose of the Study:

• To compare the safety and efficacy of continuous intravenous heparin therapy versus intermittent bolus heparin therapy.
• To evaluate the incidence of major bleeding complications and thromboembolic events between the two heparin administration methods.

Main Methods:

• Randomized controlled trial involving 41 patients indicated for heparin therapy.
• Patients were randomized to receive either continuous intravenous heparin or intermittent (four-hourly bolus) heparin.
• Activated partial thromboplastin time (aPTT) was used for therapeutic monitoring.

Main Results:

• Seven of 21 patients on intermittent heparin experienced major bleeding, versus none of 20 on continuous therapy (P = .005).
• One patient on continuous therapy had a pulmonary embolism; no recurrent thromboembolism occurred in the intermittent group.
• Two patients with severe bleeding on intermittent therapy were switched to continuous treatment.

Conclusions:

• Continuous intravenous heparin therapy demonstrates significantly improved safety regarding hemorrhagic complications compared to intermittent bolus administration.
• Continuous heparin infusion may be a preferred method for reducing bleeding risk in patients requiring anticoagulation.